Ablynx N.V.
Records under this name other than the patents Ablynx N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 145 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,017,662 | Anti-Tnf Alpha Producing Lactic Acid Bacteria for the Treatment of Chronic Enterocolitis now held by Intrexon Actobiotics N.V. In force · High confidence | In force | High confidence | |
| US 8,703,135 | Biological Materials Related to C-Met now held by Sanofi In force · High confidence | In force | High confidence | |
| US 9,573,992 | Serum Albumin Binding Proteins now held by Sanofi In force · High confidence | In force | High confidence | |
| US 9,683,045 | Biological Materials Related to C-Met now held by Sanofi In force · High confidence | In force | High confidence | |
| US 10,858,418 | Techniques for Predicting, Detecting and Reducing Aspecific Protein Interference in Assays Involving Immunoglobulin Single Variable Domains now held by Sanofi In force · High confidence | In force | High confidence | |
| US 11,192,937 | Techniques for Predicting, Detecting and Reducing Aspecific Protein Interference in Assays Involving Immunoglobulin Single Variable Domains now held by Sanofi In force · High confidence | In force | High confidence | |
| US 11,192,938 | Serum Albumin Binding Proteins Containing Immunoglobulin Single Variable Domains now held by Sanofi In force · High confidence | In force | High confidence | |
| US 11,644,471 | Techniques for Predicting, Detecting and Reducing Aspecific Protein Interference in Assays Involving Immunoglobulin Single Variable Domains now held by Sanofi In force · High confidence | In force | High confidence | |
| US 12,006,352 | Techniques for Predicting, Detecting and Reducing Aspecific Protein Interference in Assays Involving Immunoglobulin Single Variable Domains now held by Sanofi In force · High confidence | In force | High confidence | |
| US 12,630,609 | Techniques for Predicting, Detecting and Reducing Aspecific Protein Interference in Assays Involving Immunoglobulin Single Variable Domains now held by Sanofi In force · High confidence | In force | High confidence |